MIAMI, Fla., July 7, 2025 /PRNewswire/ — Sitero, a leading provider of clinical and regulatory services, today announced that it has signed a definitive agreement to acquire the assets and business of Axiom Real-Time Metrics Inc. from its proposed court-appointed receiver and manager, KSV Restructuring Inc., Axiom is recognized for its innovation in eClinical solutions and full-service global clinical operations.
This transaction, if completed, marks a significant milestone for Sitero and its ability to deliver flexible, efficient, and technology-enabled services to the global life sciences community. Since its founding in 2001, Axiom has supported hundreds of global clinical trials spanning Phase I to Phase IV across device, pharmaceutical, and biotech sectors.
The proposed transaction remains subject to a number of conditions including Sitero’s ability to obtain consent from certain customers. The transaction is also subject to approval of the Ontario Superior Court of Justice (Commercial List) in proposed receivership proceedings of Axiom, which hearing is scheduled for Friday July 11, 2025. If the transaction is approved by the Court, Sitero plans to close the transaction by July 15, 2025 in order to provide an efficient transition for customers.
Sitero’s acquisition of the Axiom platform will further Sitero’s mission to accelerate clinical development through modern, tech-enabled solutions tailored to the evolving needs of sponsors. By integrating Axiom’s proprietary eClinical Fusion platform and deep data expertise, Sitero advances its position as a next-generation clinical services partner offering comprehensive technology and clinical operations support.
“We will be thrilled to welcome Axiom to the Sitero family,” said Sankesh Abbhi, CEO of Sitero. “The Axiom platform is known for delivering innovative, customer-centric clinical solutions. With this acquisition, we will form a more powerful platform, ensuring continuity for clients while expanding our ability to deliver global trials with greater agility and scale.”
Sitero’s investment in advanced technology, data-driven infrastructure, and process innovation complements Axiom’s capabilities in eClinical software and full-service clinical delivery. Clients from both organizations will benefit from an expanded global presence and enhanced service offerings.
Upon closing, the acquisition will also advance the integration of AI-driven capabilities into Sitero’s proprietary Mentor eClinical suite. Leveraging Axiom’s proven platform and Sitero’s ongoing AI investments, the combined organization is positioned to drive significant efficiency gains, improve trial oversight, and reduce development timelines across clinical programs.
About Sitero
Sitero is a next-generation clinical research partner supporting life sciences and institutional research organizations in bringing treatments to market safer and faster. Through a technology-forward approach, Sitero streamlines research, drives compliance, and unlocks innovation. With global offices in the US, UK, Canada, Poland, Australia, Mexico, and India, Sitero combines expert talent with agile execution across its clinical, regulatory, and safety service lines.
Media Contact:
Logan Glynn
Marketing
[email protected]
561-537-0698
SOURCE Sitero, LLC
